Royalty Pharma plc (RPRX) Files Form 13D/A on June 16
Published on 6/17/2026

AI Summary
Royalty Pharma plc (RPRX) filed a Form 13D/A indicating a change in beneficial ownership of its stock as of June 16. This filing typically denotes significant shareholder activity and may impact investor perceptions of the company. The document provides insights into the ownership structure, which can affect stock liquidity and market dynamics. Changes in large shareholdings are closely watched by investors and analysts as they may signal shifts in market strategy or company confidence.
Related News

Regulation
Republic Bancorp Inc (RBCA) Announces DEF 14A Filing on June 18
Jun 19

Regulation
TEVA Form 144 Filed on June 18 for Regulatory Compliance
Jun 19

Regulation
Dali (DALI) Chief Engineer Deferred Prosecution Over 2024 Bridge Collapse
Jun 18

Regulation
Comstock Holding Companies Inc (CHCI) Form 4 Filed June 18
Jun 18